Cigna Group Quarterly Operating Income (Loss) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cigna Group quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q2 2024.
  • Cigna Group Operating Income (Loss) for the quarter ending June 30, 2024 was $2.41B, a 8.6% increase year-over-year.
  • Cigna Group Operating Income (Loss) for the twelve months ending June 30, 2024 was $8.97B, a 10.3% increase year-over-year.
  • Cigna Group annual Operating Income (Loss) for 2023 was $8.54B, a 1.02% increase from 2022.
  • Cigna Group annual Operating Income (Loss) for 2022 was $8.45B, a 6.41% increase from 2021.
  • Cigna Group annual Operating Income (Loss) for 2021 was $7.94B, a 2.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.97B $2.41B +$191M +8.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $8.78B $2.26B +$241M +12% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $8.54B $2.06B +$311M +17.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $8.23B $2.24B +$98M +4.58% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $8.13B $2.22B -$150M -6.33% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $8.28B $2.02B -$173M -7.91% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $8.45B $1.75B +$206M +13.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $8.24B $2.14B -$152M -6.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $8.4B $2.37B +$224M +10.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $8.17B $2.19B +$231M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $7.94B $1.54B +$198M +14.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $7.74B $2.29B +$186M +8.82% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $7.56B $2.15B -$492M -18.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $8.05B $1.96B -$104M -5.05% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $8.15B $1.35B -$216M -13.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $8.37B $2.11B -$15M -0.71% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $8.38B $2.64B +$476M +22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $7.91B $2.06B -$169M -7.58% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $8.08B $1.56B +$1B +179% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $7.08B $2.12B +$991M +87.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.08B $2.16B +$1B +86.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $5.08B $2.23B +$922M +70.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $4.16B $559M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.13B Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $1.16B Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.31B Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.